|
Market Cap (16-May) $8,414,961,152 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (5-May) 16,072,273 (4.76%) (53rd) |
|
52w High $31.97 |
52w Low $14.42 |
P/E 57.80 |
EPS 0.15 |
TLX released this announcement to the ASX on 14 December 2020, 8:23. The announcement is marked as price sensitive, and is 1 page(s) in length and 208.43kb in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 0.038% short sold according to ASIC data. It was ranked the 476th most shorted stock on the ASX. It is now ranked as the 53rd most shorted stock on the ASX with 4.757% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Telix Completes Acquisition of TheraPharm GmbH | 14 December 2020, 8:23 |
| Telix and Kanazawa University Phase I trial of TLX591-CDx | 14 December 2020, 8:23 |
| Release of shares from voluntary escrow | 10 December 2020, 8:20 |
| FDA New Drug Application for TLX591-CDx Proceeds to Review | 9 December 2020, 8:21 |
You must be logged in to post a reply.
Telix Pharmaceuticals 